ArticleCancers2020

mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus.

Fabio Gelsomino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.